Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
10.1007/s12035-025-04703-0 61 LiY.JiangJ.LiJ.LiuS.WangC.YuZ.et al (2025b)
FAQ Frequently Asked Questions About GHK-Cu What is GHK-Cu used for in research
About Us Doctors Data, Inc
PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165
It is composed of three amino acids- cysteine, glutamate and glycine
Heres a general overview of the dosage: Initial Phase : Dosage : 600 to 1200 mg per week Frequency : 1 to 2 injections per week Duration : 1 to 3 months Maintenance Phase : Dosage : 600 to 1200 mg per month Frequency : 1 injection per month Duration : Ongoing, based on desired results Administration Methods: Intravenous (IV) Injection/Drip:
US$ 29.04
US$ 22.14
US$ 24.78
